BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Study Demonstrates the Effectiveness of Rare Medical Network Content Marketing Programs in Rare Disease Education

  The Rare Medical Network (RMN) announced the results of a study designed to measure the educational value of the RMN specialty-specific websites to healthcare professionals.

  April 27, 2023

   · 

  3 min read
• Deals

  McKesson Corporation Declares Quarterly Dividend - April 27, 2023

  The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock.

  April 27, 2023

   · 

  1 min read
• Business

  Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance

  Ipsen, a global specialty-driven biopharmaceutical company, presents its sales performance for the first quarter of 2023.

  April 27, 2023

   · 

  13 min read
• Business

  Medivir AB - Interim Report January - March 2023

  Thanks to the strong interest from clinicians and patients, we were able to swiftly dose the first patients in the phase 2a part of the combination study with fostrox and Lenvima® in HCC after completed dose escalation.

  April 27, 2023

   · 

  5 min read
• Policy

  NeoDynamics, Inc. Announces U.S. Availability of NEONAVIA, the First and Only Pulse Biopsy Technology, FDA-Cleared in Breast and Axillary Lymph Node Biopsies

  NeoDynamics, Inc. announced the U.S. availability of NEONAVIA, the first and only biopsy system built on a patented pulse technology for controlled and precise needle insertion.

  April 27, 2023

   · 

  2 min read
• Business

  West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend

  West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2023 and updated full-year 2023 financial guidance.

  April 27, 2023

   · 

  14 min read
• Deals

  Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio

  Quest Diagnostics and Haystack Oncology announced a definitive agreement for Quest to acquire Haystack in an all-cash equity transaction.

  April 27, 2023

   · 

  5 min read
• Genetown

  KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop

  KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 13th C1-inhibitor Deficiency & Angioedema Workshop taking place in Budapest, Hungary from May 4-7.

  April 27, 2023

   · 

  3 min read
• Business

  Veru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023

  Veru Inc. announced it will host a conference call and audio webcast on Thursday, May 11, 2023, at 8:00 a.m. ET to discuss its fiscal 2023 second quarter financial results and provide a business update.

  April 27, 2023

   · 

  7 min read
• Business

  Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

  Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the first quarter ended March 31, 2023.

  April 27, 2023

   · 

  14 min read